Markets › United States › NAS › ABEO

Abeona Therapeutics Inc

NAS:ABEOHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$4.41−0.45%At closeAt close · Tue 20 Oct · ≈ AED 16.20 · Market cap $252.18M · Next earnings Wed 11 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	68.2%	54.1%	—	73.7%	—	—
Operating margin	−814.2%	−2,994.5%	−3,600.8%	−1,346.7%	—	−1,536.9%	−1,536.9%	+0.0 pts
Net margin	−842.3%	−2,831.2%	−2,807.4%	−1,548.2%	—	1,223.1%	1,223.1%	+0.0 pts
EBITDA margin	−745.2%	−2,560.5%	−2,431.6%	−1,444.9%	—	1,350.3%	—	—
Return on equity	−82.1%	−200.5%	−148.3%	−365.5%	−144.7%	44.7%	44.7%	+0.0 pts
Return on assets	−55.7%	−106.7%	−61.8%	−84.7%	−58.5%	32.4%	32.4%	+0.0 pts
Return on capital employed	−74.5%	−142.7%	−90.2%	−93.2%	−69.5%	−47.1%	—	—
Debt / equity	0.1×	0.2×	0.3×	0.4×	0.5×	0.2×	0.2×	+0.0%
Debt / assets	5.8%	11.8%	11.9%	8.4%	21.2%	11.4%	—	—
Interest coverage	−19.8×	−24.6×	−69.2×	−112.8×	−15.3×	−23.9×	—	—
Current ratio	2.3×	3.4×	6.8×	4.2×	6.1×	6.9×	6.9×	+0.0%
Quick ratio	2.3×	3.4×	6.8×	4.2×	6.1×	6.7×	—	—
Cash ratio	0.3×	2.0×	1.8×	1.1×	1.4×	2.7×	2.7×	+0.0%
Asset turnover	0.1×	0.0×	0.0×	0.1×	0.0×	0.0×	—	—
Inventory turnover	—	—	—	—	—	0.3×	—	—
Receivables turnover	—	1.0×	7.5×	1.4×	0.0×	0.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—